Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference47 articles.
1. Goodman CW, Brett AS. Gabapentin and pregabalin for pain—is increased prescribing a cause for concern? N Engl J Med. 2017;377(5):411–4. https://doi.org/10.1056/NEJMp1704633.
2. Peckham AM, Ananickal MJ, Sclar DA. Gabapentin use, abuse, and the US opioid epidemic: the case for reclassification as a controlled substance and the need for pharmacovigilance. Risk Manag Healthc Policy. 2018;11:109–16. https://doi.org/10.2147/RMHP.S168504.
3. Jones MR, Viswanath O, Peck J, Kaye AD, Gill JS, Simopoulos TT. A brief history of the opioid epidemic and strategies for pain medicine. Pain Ther. 2018;7(1):13–21. https://doi.org/10.1007/s40122-018-0097-6.
4. National Institute on Drug Abuse (NIDA). The federal response to the opioid crisis. https://www.drugabuse.gov/about-nida/legislative-activities/testimony-to-congress/2017/federal-response-to-opioid-crisis Accessed 1 Nov 2020.
5. Drug Enforcement Administration. Prescription monitoring programs: creating a national network. https://www.deadiversion.usdoj.gov/mtgs/drug_chemical/2014/droz.pdf#search=State%20prescription%20drug%20monitoring%20programs. Accessed 1 Nov 2020.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献